Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

NCT06950385 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Adenomatous Polyposis (FAP)

Interventions

DRUG: eRapa (encapsulated rapamycin)
DRUG: Placebo

Sponsor

Rapamycin Holdings Inc.

Collaborators

[object Object]